Latest Breaking News On - Protagonist therapeutics - Page 8 : comparemela.com

Insider Selling: Protagonist Therapeutics, Inc (NASDAQ:PTGX) CFO Sells $30,985 74 in Stock

Insider Selling: Protagonist Therapeutics, Inc (NASDAQ:PTGX) CFO Sells $30,985 74 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Asif aliJpmorgan chase coProtagonist therapeutics incAmeritas investment partners incRoyal bankTower research capitalChina universal asset management coProtagonist therapeuticsGet free reportUniversal asset managementResearch capitalAmeritas investment partnersInvestment partnersProtagonist therapeutics daily

Obermeyer Wood Investment Counsel Lllp Sells 1,726 Shares of Protagonist Therapeutics, Inc (NASDAQ:PTGX)

Obermeyer Wood Investment Counsel Lllp lowered its position in Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 12.5% in the 4th quarter, Holdings Channel reports. The fund owned 12,066 shares of the company’s stock after selling 1,726 shares during the quarter. Obermeyer Wood Investment Counsel Lllp’s holdings in Protagonist Therapeutics were worth $277,000 as of […]

United statesAsif aliSecurities exchange commissionChina universal asset management coJpmorgan chase coProtagonist therapeutics incProtagonist therapeutics company profileAmeritas investment partners incBoard of administration florida retirement systemHoldings channelPrincipal financial group incObermeyer wood investment counsel lllpProtagonist therapeuticsFree reportWood investment counsel lllpUniversal asset management

Obermeyer Wood Investment Counsel Lllp Reduces Stake in Protagonist Therapeutics, Inc (NASDAQ:PTGX)

Obermeyer Wood Investment Counsel Lllp lessened its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) by 12.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 12,066 shares of the company’s stock after selling 1,726 shares during the quarter. Obermeyer Wood Investment […]

Hong kongWilliamd waddillAmeritas investment partners incJpmorgan chase coProtagonist therapeutics incChina universal asset management coSecurities exchange commissionHong kong ltdRoyal bankTower research capitalObermeyer wood investment counsel lllpProtagonist therapeuticsFree reportWood investment counsel lllpUniversal asset managementResearch capital

Takeda gains rights to Kumquat s immune-oncology programme in deal worth over $1 2bn

Takeda gains rights to Kumquat s immune-oncology programme in deal worth over $1 2bn
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Yi liuKumquat biosciencesKhanh morrowProtagonist therapeuticsF star therapeutics

The EPIC Act is the bipartisan fix North Carolina patients deserve

U.S. Congressman Greg Murphy recently introduced a bill that could make an enormous difference for patients while protecting hundreds of thousands of good-paying North Carolina jobs.

North carolinaUnited statesGreg murphyJohn stanfordBrett guthrieLaura gunterCarolina life sciences organization nclifesciUniversity of chicagoEnsuring pathwaysInnovative curesInflation reductionCongressmen don davisTar heelVir biotechnologyProtagonist therapeuticsCongressman murphy